Semarion - company
Cambridge, GB · Founded 2018 · 14 employees on LinkedIn · 6 known investors
Find your way into Semarion - company
1,138 people in our graph share verified history with the Semarion - company team — schools, employers, funds. One of them is your warm intro.
Sridhar Ramaswamyunlockedknows Tarun Vemulkar · together at University of Cambridge (overlapped)
×4knows the team · via University of Pennsylvania
knows the team · via University of Cambridge
knows the team · via Katholieke Universiteit Leuven
knows the team · via MIT
×2knows the team · via Vlerick Business School
Semarion is a University of Cambridge spin-out developing the SemaCyte platform, which converts adherent cells into barcoded, ready-to-use reagents for accelerated drug discovery and cell-based research. The platform combines materials engineering and cell biology to enable researchers to multiplex cell models and increase throughput in pharmaceutical assays.
Founders & leadership
Semarion - company was founded in 2018 by Jeroen Verheyen and Tarun Vemulkar.
JV
Jeroen VerheyeninCEO and Co-FounderJeroen Verheyen holds degrees in Biomedical Sciences and Nanotechnology (both MSc, Magna Cum Laude) and has conducted research across diagnostics, stem cell therapy, drug delivery, nanomaterials, and biosensors. He is CEO and Co-Founder of Semarion, a University of Cambridge spin-out developing a microcarrier platform that converts adherent cells into reagents for drug discovery.
TV
Tarun VemulkarinCo-founder & CTOTarun Vemulkar is Co-founder and CTO of Semarion, a University of Cambridge spin-out developing cell-based reagents for drug discovery. He has previously worked on microchip fabrication processes in industry and completed doctoral research in nanomagnetic therapy approaches.
Investors · 6
Frequently asked questions
- What does Semarion - company do?
- Semarion is a University of Cambridge spin-out developing the SemaCyte platform, which converts adherent cells into barcoded, ready-to-use reagents for accelerated drug discovery and cell-based research. The platform combines materials engineering and cell biology to enable researchers to multiplex cell models and increase throughput in pharmaceutical assays.
- Who founded Semarion - company?
- Semarion - company was founded by Jeroen Verheyen, Tarun Vemulkar in 2018.
- Who are Semarion - company's investors?
- Semarion - company's investors include Cambridge Capital Group, Found Capital, Start Codon, The FSE Group, EMV Capital, Martlet Capital.
- Where is Semarion - company headquartered?
- Semarion - company is headquartered in Cambridge, GB.